ELANE and neoplasm: Our results demonstrate that the activation of PAM signaling and tumorigenesis-associated proteins are efficiently downregulated by Myr-NE treatment, leading to a significant decrease in tumor growth compared to Myricetin alone in TNBC xenografts.